⌘K

Login Start Free

Home/Filings/4/0001209191-23-011248

4//SEC Filing

DENYES NANCY 4

Accession 0001209191-23-011248

CIK 0001339970other

View on SEC.gov Company Profile

Filed

Feb 20, 7:00 PM ET

Accepted

Feb 21, 5:00 PM ET

Size

5.6 KB

Accession

0001209191-23-011248

Insider Transaction Report

Form 4

Period: 2023-02-16

aTYR PHARMA INCLIFE

General Counsel

Transactions

Award
Employee Stock Option (right to buy)
2023-02-16+84,023→ 84,023 total
Exercise: $2.19Exp: 2033-02-16→ Common Stock (84,023 underlying)

Footnotes (1)

[F1]The shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning March 16, 2023, such that this option will be fully exercisable on February 16, 2027. This option is subject to accelerated vesting upon termination without cause upon change of control of the issuer.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

aTYR PHARMA INC

CIK 0001339970

Entity typeother

Related Parties

1

filerCIK 0001640869

Filing Metadata

Form type: 4
Filed: Feb 20, 7:00 PM ET
Accepted: Feb 21, 5:00 PM ET
Size: 5.6 KB

View on SEC.gov